Search

everythinglearnresearchcommunity

for

Search:↓

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

Early scar classification in lupus can improve treatment and patient outcomes.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Hydroxychloroquine effectively treated a woman's lupus skin issues and hair loss.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Early and accurate diagnosis is crucial for effectively managing hair loss in lupus and alopecia areata.

Tislelizumab can cause cutaneous lupus erythematosus.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Careful histologic examination is crucial to differentiate types of bullous lesions in cutaneous lupus erythematosus.

Cutaneous lupus can cause permanent hair loss by damaging hair follicles.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.